Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MACS: Ciclesonide for Airway Hyperresponsiveness
NCT00826969Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Sep 2008
- Primary completion
- Jul 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of ciclesonide in asthma, sponsored by AstraZeneca. Started Sep 2008; status: completed.
02
Drugs
ciclesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00826969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00826969.